Women, power and cancer:

A Lancet Commission

 

Dr Freddie Bray

 

Freddie Bray

Dr Bray is Section Head of the Cancer Surveillance Section at the International Agency  for Research on Cancer (IARC), in Lyon, France. His areas of research revolve around  the descriptive epidemiology of cancer. These include estimation of the global cancer burden and the  analysis of time trends of cancer, including predictions of the future scale and profile of cancer and  linkages to human development transitions. In support of the overwhelming need for high quality cancer  surveillance systems, Dr Bray leads the Global Initiative for Cancer Registration development (GICR,  http://gicr.iarc.fr), an international multi-partner programme designed to ensure a sustainable expansion  of the coverage and quality of population-based cancer registries in LMIC. A key mechanism in  achieving this goal is the provision of tailored support and advocacy to individual countries through local  expert guidance via six region-wide Hubs worldwide.  

 


APPOINTMENTS 


July 2014 - Head, Cancer Surveillance Branch,  
International Agency for Research on Cancer 
Apr 2010 - Deputy Section Head, Section of Cancer Information,  International Agency for Research on Cancer 
Mar 2005 - Mar 2010 Leader, Research Section, Dept of Clinical and Registry-based  Research 
Institute of Population-Based Cancer Research, Oslo, Norway 
Jan 2007 - Mar 2010 Research Fellow, Department of Biostatistics, University of Oslo,  Norway 
Oct 1998 - Feb 2005 Scientist, Unit of Descriptive Epidemiology, IARC, Lyon, France  Dec 1996 – Sept 1998 Research Associate, Unit of Applied Epidemiology, University of the  West of England, Bristol, England 
Oct 1994 – Nov 1996 Research Assistant, South Western Cancer Registry Cancer  Epidemiology Unit, University of Bristol, Bristol, England 
EDUCATION & QUALIFICATIONS 
2002 - 2005 PhD Temporal studies of cancer occurrence and applications of the age period- cohort method to trends in Europe.  
Department of Epidemiology and Population Health, London School of  
Hygiene and Tropical Medicine, London, England 
1993 - 1994 MSc Medical Statistics University of Leicester, Leicester, England 1989 - 1993 BSc (Hons) Statistics. Grade II(i) Aberdeen University, Aberdeen, Scotland 


COMMITTEES, BOARDS, DUTIES ETC. (2005-) 


• Co-Chair, Covid-19 and Cancer Global Modelling Consortium (2020-)  
• Scientific Advisory Board, Danish Cancer Society Research Center (2018-) • Executive Secretary, International Association of Cancer Registries (2008-10, 2014-) • Member, European Network of Cancer Registries Steering Committee (2005-2010, 2014-) • International Scientific Advisory Committee, Canadian Partnership Against Cancer (2009-2011) • General Secretary, International Association of Cancer Registries (2008-10) • Chair, European Network of Cancer Registries Steering Committee (2007-9) • Editorial Board, Cancer Epidemiology (2009-); BMC Public Health (2011-14),  • Editor-in-Chief, Cancer in Norway (2006-2009); Annals of Cancer Epidemiology (2017-) • Served as an external reviewer of applications/proposals to the Swiss Cancer League, National  
Cancer Institute of Canada and the Health Research Board of Ireland; Served as external  reviewer/opponent for doctoral dissertations at the University of Helsinki, Tampere School of  Public Health and Homi Babh National Institute, Mumbai.